CLINICAL & PIPELINE·Drug Approval
Dr. Reddy's Laboratories' Divalproex Sodium ANDA: A Decade of Sustained Generic Market Presence and Regulatory Activity
Dr. Reddy's Laboratories Ltd. secured its Abbreviated New Drug Application (ANDA) for Divalproex Sodium (ANDA078979) on January 23, 2009, establishing a long-standing presence in the generic market. This approval, followed by numerous labeling supplements, underscores the mature competitive landscape and the continuous regulatory compliance demands for this oral prescription drug, impacting procurement and regulatory strategies.
90-Day Activity